Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 56, 2022 - Issue 3
Journal homepage
1,011
Views
1
CrossRef citations to date
0
Altmetric
Articles

Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience

Suleiman Abuhasaneina Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden;b Department of Surgery, Urology Section, NU Hospital Group, Trollhättan, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3756-0397View further author information
ORCID Icon,
Staffan Jahnsonc Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, SwedenView further author information
,
Firas Aljaberyc Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, SwedenView further author information
,
Truls Gårdmarkd Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0003-4610-0771View further author information
ORCID Icon,
Tomas Jerlströme Department of Urology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, SwedenORCID Iconhttps://orcid.org/0000-0003-4615-5238View further author information
ORCID Icon,
Fredrik Liedbergf Department of Urology, Skåne University Hospital, Malmö, Sweden;g Institution of Translational Medicine, Lund University, Malmö, SwedenORCID Iconhttps://orcid.org/0000-0001-8193-0370View further author information
ORCID Icon,
Amir Sherifh Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenORCID Iconhttps://orcid.org/0000-0002-3675-3050View further author information
ORCID Icon,
Viveka Ströcka Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden;i Department of Urology, Sahlgrenska University Hospital, Region Västra Götaland, Göteborg, SwedenORCID Iconhttps://orcid.org/0000-0003-2050-6466View further author information
ORCID Icon &
Henrik Kjölhedea Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden;i Department of Urology, Sahlgrenska University Hospital, Region Västra Götaland, Göteborg, SwedenORCID Iconhttps://orcid.org/0000-0001-6441-4729View further author information
ORCID Icon show all
Pages 227-232 | Received 27 Oct 2021, Accepted 23 Mar 2022, Published online: 07 Apr 2022

References

  • Babjuk MB, Compérat E. EAU guidelines on non muscle invasive bladder cancer. Eur Urol. 2020:8–14.
  • Jahnson S, Hosseini Aliabad A, Holmang S, et al. Swedish National Registry of Urinary Bladder Cancer: no difference in relative survival over time despite more aggressive treatment. Scand J Urol. 2016;50(1):14–20.
  • Svenska nationella kvalitetsregistret för Urinblåse- och urinvägscancer (SNRUBC). 2021. Available from: https://statistik.incanet.se/Urinblasecancer/.
  • Shapley M, Mansell G, Jordan JL, et al. Positive predictive values of >/=5% in primary care for cancer: systematic review. Br J Gen Pract. 2010;60(578):e366–e377.
  • Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284.
  • Wallace DMA, Bryan RT, Dunn JA, et al. Delay and survival in bladder cancer. BJU Int. 2002;89(9):868–878.
  • Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300–310.
  • Bourgade V, Drouin SJ, Yates DR, et al. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival. World J Urol. 2014;32(2):475–479.
  • Gore JL, Lai J, Setodji CM, et al. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer. 2009;115(5):988–996.
  • Russell B, Liedberg F, Khan MS, et al. A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients. Eur Urol Oncol. 2020;3(2):239–249.
  • Blick C, Bailey D, Haldar N, et al. The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK institution. Ann R Coll Surg Engl. 2010;92(1):46–50.
  • Nilbert M, Blackberg M, Ceberg J, et al. Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria. Scand J Urol. 2018;52(4):237–243.
  • Malmström PU, Gårdmark T, Sherif A, et al. Incidence, survival and mortality trends of bladder cancer in Sweden 1997–2016. Scand J Urol. 2019;53(4):193–199.
  • Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 8th ed. Hoboken (NJ): JJohn Wiley and sons; 2017.
  • Busch C, Algaba F. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Arch. 2002;441(2):105–108.
  • McCombie SP, Bangash HK, Kuan M, et al. Delays in the diagnosis and initial treatment of bladder cancer in Western Australia. BJU Int. 2017;120:28–34.
  • Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56–72.
  • Harshman LC, Tripathi A, Kaag M, et al. Contemporary patterns of multidisciplinary care in patients with muscle-invasive bladder cancer. Clin Genitourin Cancer. 2018;16(3):213–218.
  • Zhou Y, Walter FM, Singh H, et al. Prolonged diagnostic intervals as marker of missed diagnostic opportunities in bladder and kidney cancer patients with alarm features: a longitudinal linked data study. Cancers. 2021;13(1):156.
  • Chawla A, Westrich K, Dai A, et al. US care pathways: continued focus on oncology and outstanding challenges. Am J Manag Care. 2019;25(6):280–287.
  • Waisbrod S, Natsos A, Wettstein MS, et al. Assessment of diagnostic yield of cystoscopy and computed tomographic urography for urinary tract cancers in patients evaluated for microhematuria: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(5):e218409.
  • Linder BJ, Bass EJ, Mostafid H, et al. Guideline of guidelines: asymptomatic microscopic haematuria. BJU Int. 2018;121(2):176–183.
  • Malmstrom PU, Skaaheim Haug E, Bostrom PJ, et al. Progress towards a Nordic standard for the investigation of hematuria: 2019. Scand J Urol. 2019;53(1):1–6.
  • Hughes-Hallett A, Browne D, Mensah E, et al. Assessing the impact of mass media public health campaigns. Be clear on cancer ‘blood in pee’: a case in point. BJU Int. 2016;117(4):570–575.
  • Koo MM, Swann R, McPhail S, et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21(1):73–79.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.